Comparison

3’,5’-Bis(O-t-butyldimethylsilyl)-4’-C-hydroxymethyl thymidine European Partner

Item no. TMO-TNU1323-500mg
Manufacturer TargetMol
CASRN 179178-45-1
Amount 500 mg
Quantity options 100 mg 10 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles C(O[Si](C(C)(C)C)(C)C)[C@]1(CO)[C@@H](O[Si](C(C)(C)C)(C)C)C[C@@H](O1)N2C(=O)NC(=O)C(C)=C2
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping condition Cool pack
Available
Manufacturer - Targets
RIP kinase|||Apoptosis|||c-Met/HGFR
MET, HGF
Shipping Temperature
cool pack
Storage Conditions
-20°
Molecular Weight
512, 53
Description
RIPK3-IN-1 is a selective and potent RIPK3 inhibitor (IC50: 9.1 nM) that inhibits the activities of c-Met kinase, RIPK1 and RIPK2.RIPK3-IN-1 has potential tumorigenic activity and can be used to study apoptosis.
Pathways
NF-Κb|||Tyrosine Kinase/Adaptors|||Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close